PURPOSE: Necrotizing enterocolitis (NEC) is a serious condition, predominantly observed in premature infants. We used an experimental NEC model to investigate the effects of vascular endothelial growth factor (VEGF) cloned into a plasmid. MATERIALS AND METHODS: Twenty-four newborn Wistar albino rats were randomized equally into three groups as follows: control, NEC and NEC+VEGF. NEC was induced by hyperosmolar enteral formula feeding, exposure to hypoxia/reoxygenation and cold stress. In the NEC+VEGF group, VEGF (1 μg) incorporated into plasmid (2 μg) was administered subcutaneously once daily for a total of 3 days starting on the first day of the NEC procedure. All rats were sacrificed on the 4th day of life, and the specimens were harvested for histopathological and biochemical examinations [including tissue oxidative stress (malondialdehyde and nitric oxide), inflammation (myeloperoxidase, interleukin-6 and tumor necrosis factor alpha) and apoptosis (caspase-3 activity) parameters]. RESULTS: In the NEC+VEGF group, tissue malondialdehyde, nitric oxide, interleukin-6, tumor necrosis factor alpha levels and caspase-3 activity were significantly decreased. In addition, the myeloperoxidase level was increased compared to that of the NEC group (p < 0.05). Histopathologically, VEGF overexpression enhanced angiogenesis, alleviated villous atrophy and tissue edema (p < 0.05). CONCLUSION: VEGF overexpression with plasmids seems to be a promising approach in the management of NEC.
PURPOSE:Necrotizing enterocolitis (NEC) is a serious condition, predominantly observed in premature infants. We used an experimental NEC model to investigate the effects of vascular endothelial growth factor (VEGF) cloned into a plasmid. MATERIALS AND METHODS: Twenty-four newborn Wistar albino rats were randomized equally into three groups as follows: control, NEC and NEC+VEGF. NEC was induced by hyperosmolar enteral formula feeding, exposure to hypoxia/reoxygenation and cold stress. In the NEC+VEGF group, VEGF (1 μg) incorporated into plasmid (2 μg) was administered subcutaneously once daily for a total of 3 days starting on the first day of the NEC procedure. All rats were sacrificed on the 4th day of life, and the specimens were harvested for histopathological and biochemical examinations [including tissue oxidative stress (malondialdehyde and nitric oxide), inflammation (myeloperoxidase, interleukin-6 and tumor necrosis factor alpha) and apoptosis (caspase-3 activity) parameters]. RESULTS: In the NEC+VEGF group, tissue malondialdehyde, nitric oxide, interleukin-6, tumor necrosis factor alpha levels and caspase-3 activity were significantly decreased. In addition, the myeloperoxidase level was increased compared to that of the NEC group (p < 0.05). Histopathologically, VEGF overexpression enhanced angiogenesis, alleviated villous atrophy and tissue edema (p < 0.05). CONCLUSION:VEGF overexpression with plasmids seems to be a promising approach in the management of NEC.
Authors: G Scotland; M Beard; S Erdogan; E Huston; F McCallum; S J MacKenzie; A H Peden; L Pooley; N G Rena; A H Ross; S J Yarwood; M D Houslay Journal: Methods Date: 1998-01 Impact factor: 3.608
Authors: Cynthia D Downard; Elizabeth Renaud; Shawn D St Peter; Fizan Abdullah; Saleem Islam; Jacqueline M Saito; Martin L Blakely; Eunice Y Huang; Marjorie J Arca; Laura Cassidy; Gudrun Aspelund Journal: J Pediatr Surg Date: 2012-11 Impact factor: 2.545
Authors: Catherine van Montfrans; Anje A te Velde; Sander J H van Deventer; Maria Sol Rodriguez Pena Journal: Int J Colorectal Dis Date: 2003-06-25 Impact factor: 2.571
Authors: Laurens Kruidenier; Ineke Kuiper; Wim Van Duijn; Marij A C Mieremet-Ooms; Ruud A van Hogezand; Cornelis B H W Lamers; Hein W Verspaget Journal: J Pathol Date: 2003-09 Impact factor: 7.996
Authors: Animesh Sabnis; Rosa Carrasco; Shirley X L Liu; Xiaocai Yan; Elizabeth Managlia; Pauline M Chou; Xiao-Di Tan; Isabelle G De Plaen Journal: Neonatology Date: 2015-01-30 Impact factor: 4.035